YAP1 and cancer: While the different roles of YAP1 in oncogenesis might be tissue- and cell context-specific, elevated YAP1 signaling in cancer cells has been linked to anti-cancer therapy resistance to agents such as taxol, doxorubicin, cisplatin and tamoxifen [23–28].